LYKA LABS LTD. - 500259 - Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015
As required under Regulation 40(9) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we enclose herewith a copy of Compliance Certificate dated 23rd April, 2020 issued by Kaushal Doshi & Associates, practicing Company Secretaries for the half year ended 31St March, 2020. LYKA LABS LTD. - 500259 - Shareholding for the Period Ended March 31, 2020
Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here LYKA LABS LTD. - 500259 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Piyush HindiaDesignation :- Company Secretary and Compliance Officer LYKA LABS LTD. - 500259 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 31st March, 2020 received form M/s Sharex Dynamic (India) Pvt. Ltd, Registrar and Share Transfer Agent of the Lyka Labs Limited. LYKA LABS LTD. - 500259 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements), 2015 For The Half Year Ended 31St March, 2020
Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Compliance Certificate, duly signed by Authorized Signatory of M/s. Sharex Dynamic (India) Private Limited, Share Transfer Agent of Lyka Labs Limited ('the Company') and by the Company Secretary and Compliance Officer of the Company for the half year ended 31St March, 2020. LYKA LABS LTD. - 500259 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Lyka Labs Ltd has Clarified to BSE that "With reference to your above referred email dated 08th April, 2020 seeking clarification on the current movements in the share price of the Company, we would like to clarify as under: All the material information, that have a bearing on the operations/performance of the Company which include all price sensitive information under Regulation 30 of SEBI [Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations")], have always been disclosed by the Company within the stipulated time.Further, the Company has always provided timely clarification / information sought by the Stock Exchanges. There is no pending information or announcement from the Company which may have a bearing on the price movement of the Company. The current movement in the share price of the Company is based purely due to market conditions and absolutely market driven and the Company is in no way connected with any such movement in price." LYKA LABS LTD. - 500259 - Clarification sought from Lyka Labs Ltd
The Exchange has sought clarification from Lyka Labs Ltd on April 08, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. LYKA LABS LTD. - 500259 - Closure of Trading Window
This is to inform you that under SEBI (Prohibition of Insider Trading) Regulations,2015 and Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information,the trading window for dealing in the Equity shares of the Company by designated persons and their immediate relatives shall remain closed with effect from 01st April,2020 till 48 hours after the declaration of Financial Results for the quarter and year ended 31st March, 2020. (both days inclusive). LYKA LABS LTD. - 500259 - Closure of Trading Window
This is to inform you that under SEBI (Prohibition of Insider Trading) Regulations,2015 and Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information,the trading window for dealing in the Equity shares of the Company by designated persons and their immediate relatives shall remain closed with effect from 01st April,2020 till 48 hours after the declaration of Financial Results for the quarter and year ended 31st March, 2020. (both days inclusive). LYKA LABS LTD. - 500259 - Withdrawal Of Our Application For Preferential Issue Of Shares And Warrants To Promoters
We wish to inform you that Smt. Nehal N. Gandhi, promoter and major subscriber to proposed preferential issue has withdrawn her consent to subscribe shares and warrants offered to her on preferential basis due to non-availability of requisite approval from one of the pledgees. Consecutively, Shri. Kunal N. Gandhi and Enai Trading and Investment Private Limited of Promoters Group have also conveyed to the Company about withdrawal of their consent to subscribe Equity Shares offered to them on preferential basis.